Locust Walk
Locust Walk is a global life science transaction firm. WE BELIEVE THAT NO TWO PATHS ARE THE SAME.
Our team fuels the growth of promising biopharma companies at every stage, by connecting the right products, the right partners, and the most attractive sources of capital – driving innovation for growth and transformative results. Locust Walk operates on one powerful guiding principle: that our role is to craft and execute customized partnering and financing strategies designed to meet the specif
Congratulations to the Xyphos Biosciences team for their acquisition by Astellas. They found a great partner to help them develop next generation cell therapies and we are very proud to have worked with such a great team. Click here to read the press release:
12/12/2019
On Thursdays our Analysts match.
11/11/2019
Lubor Gaal, SVP, Head of Europe at Locust Walk, sat down with EBD Group in preparation for his panel at .
11/06/2019
Join Lubor Gaal of Locust Walk and his esteemed panelists at BIO-Europe November 12 from 10-11 am to discuss non-binding term sheets.
10/23/2019
We want you to master one of the most important elements in a successful transaction process--the handling of the term sheet! Lubor Gaal's recent article in the September issue of BiopharmaDealmakers, "Biopharma Dealmaking: Negotiating Your Term Sheet," is available now. Click below to read (pages 13-14)
https://biopharmadealmakers.nature.com/pages/npg-latest-edition-bpdm
10/11/2019
Locust Walk's medtech team has compiled key statistics and trends on strategic transactions and financings, with a focus on upcoming trends. Click below to download: http://bit.ly/Q3MedtechReport
Q3 2019 Report: Global Trends in Medtech Transactions - Locust Walk Q3 2019 Report: Global Trends in Medtech Transactions Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get t...
10/10/2019
At the end of each quarter, our biopharma team here at Locust Walk reviews the global trends in biopharma transactions with an eye on future trends. Click below to download.
http://bit.ly/Q3BioReport
09/16/2019
Based on recent acquisitions by two of the largest pharmaceutical companies, it seems as if the historical orthodoxy that great biopharma companies are made from the inside out may be losing validity. Download our whitepaper, Inside Out, written by Chris Ehrlich to join the discussion. http://bit.ly/insideoutwhitepaper
Whitepaper Download: Inside Out - Locust Walk Inside Out: Do Recent Acquisitions by “Big Pharma” Sound the Alarm for the Traditional R&D Model? Based on recent acquisition activity by two of the largest pharmaceutical companies, it seems as if the historical orthodoxy that great biopharma companies are made from the inside out may be losing...
08/21/2019
Our CEO and Co-Founder, Geoff Meyerson, just returned from a month in Europe as part of our effort to expand Locust Walk European practice. It was a fantastic trip with valuable lessons. Click below to read.
http://bit.ly/EUVacation
07/30/2019
What's the impact on partnerships for public biotech companies? Financing overhang or hangover? Click below to read more and join the discussion.
https://www.locustwalk.com/financing-overhang-or-hangover-the-impact-on-partnerships-for-public-biotech-companies/
07/17/2019
Our medtech team took a deep dive into the Q2 data. Click below to download the report on latest trends and predictions for what's ahead.
http://bit.ly/Q2Medtech
07/17/2019
As we close Q2, our global biopharma team has pulled the latest data with a keen eye on insights and trends. Click below to download!
http://bit.ly/Q2Biopharma
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
200 Clarendon Street 51st Floor
Boston, MA
02116
Opening Hours
| Monday | 8:30am - 5:30pm |
| Tuesday | 8:30am - 5:30pm |
| Wednesday | 8:30am - 5:30pm |
| Thursday | 8:30am - 5:30pm |
| Friday | 9am - 5:30pm |